COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies

Bradley J. Monk,Robert L. Coleman,Kathleen N. Moore,Thomas J. Herzog,Angeles Alvarez Secord,Ursula A. Matulonis,Brian M. Slomovitz,Saketh R. Guntupalli, David M. O'Malley

Gynecologic Oncology（2020）

引用 0|浏览0

暂无评分

摘要

•The pandemic COVID-19 requires alternative methods and thinking to keep healthcare professionals and patients safe.•In COVID-19 hot spots, oral therapies may be viable alternatives to intravenous therapies for treatment of ovarian cancer.•Minimizing patient visits to hospitals and cancer clinics may help mitigate the spread of SARS-CoV-2.

查看译文

关键词

SARS-CoV-2,COVID-19,Ovarian cancer,Oral,Targeted therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要